ZOILA VALDIVIA ASCUNA: Open Payments
NPI 1972208197 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 14 payments from 5 companies in 2025. Trend: 2023 $20 · 2024 $757 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $204 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Optinose US, Inc. | 2 | $46 |
| Hikma Pharmaceuticals USA | 1 | $19 |
Products named: DUPIXENT, NUCALA, Xhance, Ryaltris.
Industry payments across FL — which companies pay providers there.
